Select An Issue
Selected Issue:
Issue 21
9th
November 2009
C&I Magazine
C&I MagazineThe leading source of news and opinion in the arena of chemical technology
Cover Story
Confirmation of the synthesis of the elusive pentazole molecule, of interest for its possible role in future rocket propellants, has come almost a decade after it was made, writes Richard Butler
News
Vidya Krishnan,
09/11/2009
The turf war between the Indian
health ministry and office of the drug
controller general of India (DCGI)
rages on after the health ministry ‘put
on hold’ the directives issued by the
DCGI withdrawing powers from state
governments to issue Certificates
of Pharmaceutical Products (CoPP)
– the export quality licence drug
manufacturers require to sell their
drugs to overseas buyers.
Stuart Todd,
09/11/2009
French President Nicolas Sarkozy has
announced a series of measures to
facilitate the development of France’s
pharmaceuticals sector, including
the setting up of an investment
fund, InnoBio, totalling more than
€130m, to finance the development
of healthcare-related biotechnology.
Features
Hugh Constable,
09/11/2009
One of the UK’s biggest energy consumers, Ineos Chlor has improved energy
effi ciency by almost a fi fth over the past decade, writes Hugh Constable
Lou Reade,
09/11/2009
Solar power is on the rise. In 2008, the amount
of energy generated by solar cells rose by 80%.
Editor's Blog
An end to jet lag?
Agree or disagree? Post your views below
Can it be true, an end to jet lag, the bane of all international jet-setters? But could the answer also be a solution to a host of other problems including psychiatric disorders and the impact of shift work?
As Andrew Loudon from the University of Manchester says: ‘It can be really devastating to our brains and bodies when something happens to disrupt the natural rhythm of our body clocks. This can be as a result of disease or as a consequence of jet lag or frequent changing between day and night shifts at work.’